|   In the News

Startup Spotlight: Akrevia Therapeutics eyes safer immunotherapies

Akrevia Therapeutics is on a mission to make immunotherapies safer. The startup, based in the LabCentral incubator in Cambridge, Mass., is working on drug candidates that act much like therapies that are already on the market, including Bristol Myers-Squibb’s Yervoy and Clinigen’s Proleukin. It’s hoping it can find new drugs that mimic those effects but without sending the immune system into overdrive.

Read more.